Claritev Corporation Reports Third Quarter 2026 Results
Claritev Corporation reports financial results for the third quarter ended September 30, 2026.
Q3 2026 Revenues of $268.3 million grew 9.1% compared to Q3 2025
Net Loss of $61.8 million
Adjusted EBITDA of $162.0 million increased 4.4% compared to Q3 2025 (Adjusted EBITDA Margin of 60.4% versus 63.1% in Q3 2025)
MCLEAN, VA — November 9, 2026 — Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the third quarter ended September 30, 2026.
Recent news
-
Claritev Corporation Reports Third Quarter 2026 Results
Read More -
Claritev Corporation Announces Participation in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Read More -
Claritev Introduces Transparency-Based Pricing, Turning Complex Public Market Data into Actionable Reimbursement Intelligence
Read More